SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sandu Pharmaceuticals informs about loss of share certificate

05 Mar 2019 Evaluate

Sandu Pharmaceuticals has informed about loss of share certificate / issue of duplicate share certificate.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

41.80 0.29 (0.70%)
25-Jun-2026 10:16 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1881.30
Dr. Reddys Labs. 1357.00
Cipla 1440.70
Zydus Lifesciences 1104.65
Lupin 2364.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: